Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. - Test2 - elhamkhani - TriplyDB

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

http://www.wikidata.org/entity/Q28274091

about

TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets Malignant Transformation in Glioma Steered by an Angiogenic Switch: Defining a Role for Bone Marrow-Derived Cells Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues Twisted tango: brain tumor neurovascular interactions The impact of the myeloid response to radiation therapy Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy Unlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapy Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma Radiotherapy and the tumor stroma: the importance of dose and fractionation Radiation as immunomodulator: implications for dendritic cell-based immunotherapy High-resolution in-vivo analysis of normal brain response to cranial irradiation The hematopoietic chemokine CXCL12 promotes integration of human endothelial colony forming cell-derived cells into immature vessel networks Endothelial progenitor cells (EPCs) as gene carrier system for rat model of human glioma Radiation therapy-induced tumor invasiveness is associated with SDF-1-regulated macrophage mobilization and vasculogenesis Radiation-induced immune responses: mechanisms and therapeutic perspectives Cellular host responses to gliomas Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma Identifying mutation specific cancer pathways using a structurally resolved protein interaction network.Improving the radiosensitivity of radioresistant and hypoxic glioblastoma.Opportunities and challenges for successful use of bevacizumab in pediatrics.Application of optical imaging and spectroscopy to radiation biology VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue The hypoxia factor Hif-1α controls neural crest chemotaxis and epithelial to mesenchymal transition.Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors.Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma.Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting Microenvironmental regulation of therapeutic response in cancer CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas Orthotopic expression of noggin protein in cancer cells inhibits human lung carcinoma growth in vivo.CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer.

P2860

Q24606406-6C2D5E49-8000-4C7B-85C4-DDB84460EF0E Q26750420-B5D50667-420C-417A-A43C-8FDA450F9384 Q26752838-81A71BFB-1865-446D-A832-C87EE11DB5E7 Q26765758-62916CB0-C801-468D-B627-BE8FC3816C2E Q26765887-F83AE6C7-AE08-45C7-AA52-C9E33A5EAE3B Q26772259-25960448-49B5-42FE-BD78-3F599C9CC750 Q26781833-5BD89817-3F35-49E7-AD11-A3F7CEE60E57 Q26798402-CACB69FB-B1AC-4D53-B6B3-267D983744B1 Q26823489-31BB29C2-2561-4978-810E-7F4D9B72F461 Q26825769-1DFFAB2D-D080-45DB-8583-9517E9E64D49 Q26849613-C9B67178-8208-4D6A-828C-C91351D6F838 Q26851643-BFDDC86D-2CB3-4525-BA79-236135FCF13A Q26865533-0F64DED8-C9DD-4019-AC93-A3F4723809E3 Q26995698-D5033E1B-313C-4703-AF0A-F9BB5856E786 Q26999217-0501D9E0-5615-409C-BED2-8FFE67045822 Q27001216-EBD72041-2A3C-4CCD-8819-9F8177F8EC27 Q27021470-A678BA6F-05B6-469C-A5A2-52E68BD6AB84 Q27022685-6EE4A37D-A1ED-4787-A1AA-A6DEB187F636 Q27025756-58D24B30-D374-4B2E-B38D-856F439D7924 Q27301577-8C9EBCE7-5B16-4674-BF38-598CB1D74D4E Q27307132-4A128F91-3044-478F-AB96-06A2B5D25597 Q27309949-091EDE38-6A50-4923-84E9-7D9520FDA698 Q27311252-F5BFC1AD-2328-4463-BD5D-A12FD95AAE74 Q28080006-BF4A16A2-83A0-4F98-9684-AF9FC5ACDB21 Q28730429-D269DC9A-943E-408F-81A6-795FADEAF99D Q30300986-76F07D48-7DC1-4F75-B10E-83E8E072661F Q30370822-D2051F46-103A-4D8D-8E57-B5E9CCFEA9F9 Q30452219-AC11670C-AA3B-43D2-91A7-96F026636A2A Q30454883-D63AA5DC-9EB1-497B-9011-B25FCD04E95C Q30455958-7B1C1C47-E22E-4C3C-929F-8FFA61A9606D Q30528882-9C9CC1C5-2092-48EA-AF24-AFA26DE09646 Q30540087-496E5D45-5FD3-4341-A4F5-C21A52968559 Q30930526-D275F323-9BD0-4C5A-A19C-F00FDC5B6A76 Q33397543-60173CDC-21D1-4589-A737-F6C0679A5167 Q33605773-6A2B7D9F-63D1-4EC0-AECE-F80D194D9178 Q33654609-7757BD3C-513B-4668-80BE-B5B5D93DC66F Q33677057-72619E79-7158-4742-BE65-34BF04D3FB81 Q33685705-6E6A35E5-9FC3-4535-A703-749A94D1FFCC Q33864133-F7C73FEB-52C3-4765-AEA9-81AA95E641AD Q33897765-E523D904-5A50-4462-B071-35AA91112041

P2860

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

http://www.wikidata.org/entity/Q28274091

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Inhibition of vasculogenesis, ...... toma after irradiation in mice

@nl

Inhibition of vasculogenesis, ...... oma after irradiation in mice.

@ast

Inhibition of vasculogenesis, ...... oma after irradiation in mice.

@en

type

label

Inhibition of vasculogenesis, ...... toma after irradiation in mice

@nl

Inhibition of vasculogenesis, ...... oma after irradiation in mice.

@ast

Inhibition of vasculogenesis, ...... oma after irradiation in mice.

@en

prefLabel

Inhibition of vasculogenesis, ...... toma after irradiation in mice

@nl

Inhibition of vasculogenesis, ...... oma after irradiation in mice.

@ast

Inhibition of vasculogenesis, ...... oma after irradiation in mice.

@en

P1433

Q28274091-B828352D-DBBD-401B-AC73-CD1E3EC778DD

P1476

Q28274091-2C5F5B11-2185-43C8-81EC-739229CED3F7

P2093

Q28274091-07D5B3EA-E721-485D-9A9C-22FCAAF803E5

Q28274091-6ED51939-7371-4133-B182-4D02064CF44F

Q28274091-85B474E7-CAA9-4FD6-B07A-ECD4222B8A5E

Q28274091-F381B4D5-7C24-451E-8CB2-5C3234DF8F6B

P2860

Q28274091-028801C4-1755-4E7E-B2DD-281B4E307DE2

Q28274091-0B2DEF24-D8F0-4278-BEA7-31A14A3E12C3

Q28274091-10BDA876-19DE-4448-AD24-17DD54B09E8D

Q28274091-1865D80D-5522-463F-9AB1-CE4CEE612BFC

Q28274091-1993F1BF-C191-4F79-AD86-D778B60DF5C7

Q28274091-2080C5F2-C9AE-4075-B596-3415332344F8

Q28274091-22B3AD4C-D9DD-40C8-A9FF-9DCC82855179

Q28274091-251195A7-7A27-40EE-AD38-53AF4EADB215

Q28274091-260BD43C-6A50-4486-8F6E-0F8EC6149738

Q28274091-27111B65-908B-4D2D-BFCB-8668EAA2BA09

P304

Q28274091-C3C1B086-9981-4AA1-A4D1-1ED68A3E507C

P31

Q28274091-6676A26E-507C-450C-8C1F-C7F4EFF2599C

P3181

Q28274091-B435FE3E-9F44-4428-838A-D53F91D1B348

P356

Q28274091-E3D0DF1F-EE75-4A24-8227-8E7582958909

P407

Q28274091-454FC8A6-663C-48EA-B5AC-2B05C96E2912

P433

Q28274091-24ACEA99-074B-466E-AF46-C523FC41E38D

P478

Q28274091-D828AA73-BAB0-4F73-B2E5-4D12D0D90154

P50

Q28274091-3A6657C8-814C-43B9-B470-CBD7B7D78C93

Q28274091-6178DCDC-D396-43E4-AA1A-79FBBC0362CD

P577

Q28274091-7D4FB212-21D9-4428-A7B9-F5C072CE0D99

P698

Q28274091-2B416409-FBF2-4CF4-9527-BFEE109A36D5

P932

Q28274091-7B0C75DF-4DDD-4C3D-A81B-BAF3C6E3E43E

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Inhibition of vasculogenesis, ...... toma after irradiation in mice

@en

P2093

Geoffrey Schultz

http://www.w3.org/2001/XMLSchema#string

Griffith R Harsh

http://www.w3.org/2001/XMLSchema#string

J Martin Brown

http://www.w3.org/2001/XMLSchema#string

Robert M Hoffman

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche

Modes of resistance to anti-angiogenic therapy

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

Inflammation and cancer

Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration

Bone marrow cells regenerate infarcted myocardium

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

P304

694-705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

940366

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI40283

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Otto Hannes Vogel

P577

2010-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20179352

http://www.w3.org/2001/XMLSchema#string

P932

2827954

http://www.w3.org/2001/XMLSchema#string